普洛药业(000739.SZ):与西安新通签署战略合作框架协议

Core Viewpoint - Pro Pharmaceutical (000739.SZ) has signed a strategic cooperation framework agreement with Xi'an Xintong Pharmaceutical Research Co., Ltd. to engage in long-term collaboration on innovative drug research and development and custom manufacturing projects (CDMO projects) [1] Group 1 - The agreement is based on principles of equality, mutual benefit, and complementary advantages [1]

APELOA-普洛药业(000739.SZ):与西安新通签署战略合作框架协议 - Reportify